Publications

[ Author(Desc)] Title Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
L
Li X, Fries S, Li R, Lawson JA, Propert KJ, Diamond SL, Blair IA, FitzGerald GA, Grosser T.  2014.  Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 111(47):16830-5.
Liang X, Bushman FD, FitzGerald GA.  2015.  Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc Natl Acad Sci U S A. 112(33):10479-84.
Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, FitzGerald GA.  2015.  Bidirectional interactions between indomethacin and the murine intestinal microbiota.. Elife. 4
Liu R, Jin Y, Tang WHo, Qin L, Zhang X, Tellides G, Hwa J, Yu J, Martin KA.  2013.  Ten-eleven translocation-2 (TET2) is a master regulator of smooth muscle cell plasticity. Circulation. 128(18):2047-57.
Liu T, Altman RB.  2015.  Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach. J Chem Inf Model. 55(7):1483-94.
Lu Y-C, Chang S-H, Hafner M, Li X, Tuschl T, Elemento O, Hla T.  2014.  ELAVL1 Modulates Transcriptome-wide miRNA Binding in Murine Macrophages. Cell Rep. 9(6):2330-43.
M
Martin SA, Gijón MA, Voelker DR, Murphy RC.  2014.  Measurement of lysophospholipid acyltransferase activities using substrate competition. J Lipid Res. 55(4):782-91.
Mazaleuskaya LL, Sangkuhl K, Thorn CF, FitzGerald GA, Altman RB, Klein TE.  2015.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 25(8):416-26.
Mazaleuskaya LL, Theken KN, Gong L, Thorn CF, FitzGerald GA, Altman RB, Klein TE.  2015.  PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics. 25(2):96-106.
Mazaleuskaya LL, Lawson JA, Li X, Grant G, Mesaros C, Grosser T, Blair IA, Ricciotti E, FitzGerald GA.  2016.  A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood. JCI Insight. 1(12)
Moore JH, Hwa J.  2014.  Editorial: pharmacogenetics and molecular medicine: "so close and yet so far". Curr Mol Med. 14(7):803-4.
O
O'Donnell VB, Murphy RC, Watson SP.  2014.  Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets. Circ Res. 114(7):1185-203.
Obinata H, Gutkind S, Stitham J, Okuno T, Yokomizo T, Hwa J, Hla T.  2014.  Individual variation of human S1P1 coding sequence leads to heterogeneity in receptor function and drug interactions. J Lipid Res. 55(12):2665-75.
P
Prilutsky D, Kho AT, Palmer NP, Bhakar AL, Smedemark-Margulies N, Kong SWon, Margulies DM, Bear MF, Kohane IS.  2015.  Gene expression analysis in Fmr1KO mice identifies an immunological signature in brain tissue and mGluR5-related signaling in primary neuronal cultures.. Mol Autism. 6:66.
Proia RL, Hla T.  2015.  Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest. 125(4):1379-87.
R
Roberts LD, Koulman A, Griffin JL.  2014.  Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2(1):65-75.
S
Sahu RP, Harrison KA, Weyerbacher J, Murphy RC, Konger RL, Garrett JElizabeth, Chin-Sinex HJan, Ii MEdward Joh, Dynlacht JR, Mendonca M et al..  2016.  Radiation therapy generates platelet-activating factor agonists. Oncotarget.
Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK et al..  2014.  Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. Cancer Res. 74(23):7069-78.
Snyder NW, Basu SS, Zhou Z, Worth AJ, Blair IA.  2014.  Stable isotope dilution liquid chromatography/mass spectrometry analysis of cellular and tissue medium- and long-chain acyl-coenzyme A thioesters. Rapid Commun Mass Spectrom. 28(16):1840-8.
Stitham J, Vanichakarn P, Ying L, Hwa J.  2014.  Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs. Curr Mol Med. 14(7):909-31.
Stitham J, Hwa J.  2016.  Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations.. Curr Mol Med. 16(4):328-42.
T
Tang WHo, Stitham J, Jin Y, Liu R, Lee SHee, Du J, Atteya G, Gleim S, Spollett G, Martin K et al..  2014.  Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation. 129(15):1598-609.
Toung JM, Lahens N, Hogenesch JB, Grant G.  2014.  Detection theory in identification of RNA-DNA sequence differences using RNA-sequencing. PLoS One. 9(11):e112040.
V
Vanichakarn P, Hwa J, Stitham J.  2014.  Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies. Curr Mol Med. 14(7):849-79.
W
Wong AK, Krishnan A, Yao V, Tadych A, Troyanskaya OG.  2015.  IMP 2.0: a multi-species functional genomics portal for integration, visualization and prediction of protein functions and networks. Nucleic Acids Res. 43(W1):W128-33.

Pages